N-ovative Health Technologies Pvt Ltd, a NUST-based company producing health technologies, plans next month to commercially launch its very own indigenous cardiac stents.
In a Facebook post, the health technology company revealed that such stents “Aim is to make healthcare more affordable for patients.”
Indigenous healthcare products, equipment, and innovations such as cardiac stents will dramatically reduce the costs of such operations in the world. Currently, implantations based in Pakistan are using imported stents, which makes the surgery price substantially higher as import taxes and tariffs push up the total.
N-ovative also strives to bring benefits to the entire healthcare system, including hospitals, clinics, medical professionals, etc. These benefits will do wonders for the financial state of our country and create a ‘flourishing local market’ for medical technology.
In the coming weeks, the Private Limited firm intends to launch these indigenous stents within the region. Major General Ret, Major General Ret. In an interview with Samaa, Dr Azhar Mehmood Kayani, a renowned cardiologist, said that these locally-made stents could potentially be a remarkable step for Pakistan in the field of medical science. He further told Samaa that at the Rawalpindi Institute of Cardiology and then at the National Institute of Cardiovascular Diseases, Karachi, these stents had been used. Both of these experiments were successful, and no problems were found during or after the implantation process.
According to Dr Murtaza Najabat Ali, CEO of NHT, Phase One aims to produce 45% of the stents being used in the region. Step two would then involve satisfying 100 percent of the country’s demands and working for export purposes towards output.
The output capacity for the first year is 15,000, Dr. Murtaza also said. By the year 2022, this capacity will be expanded to 25,000-30,000 units.
